Little Impact Seen In Regulations Implementing China’s New M&A Law
This article was originally published in PharmAsia News
Executive Summary
Regulations implementing China's new law governing mergers and acquisitions set to go into effect Aug. 1 are likely to follow foreign models that review antitrust issues involved in mergers. The new rules are expected to require reviews in two areas - monopolies and national security. Any transaction that affects competition or consumer would be subject to review for anti-monopoly issues. Those that might have an impact on China's economic security would be subject to review for national-security issues. (Click here for more